BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26927312)

  • 1. Prognostic value of Diabetes in Patients with Nasopharyngeal Carcinoma Treated with Intensity-Modulated Radiation Therapy.
    Peng H; Chen L; Zhang Y; Li WF; Mao YP; Zhang F; Guo R; Liu LZ; Lin AH; Sun Y; Ma J
    Sci Rep; 2016 Mar; 6():22200. PubMed ID: 26927312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Impact of Plasma Epstein-Barr Virus DNA in Patients with Nasopharyngeal Carcinoma Treated using Intensity-Modulated Radiation Therapy.
    Peng H; Guo R; Chen L; Zhang Y; Li WF; Mao YP; Sun Y; Zhang F; Liu LZ; Lin AH; Ma J
    Sci Rep; 2016 Feb; 6():22000. PubMed ID: 26924234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of total tumor volume in patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy.
    Liang SB; Teng JJ; Hu XF; Yang XL; Luo M; Fang XN; Liu DS; Chen Y; Fu LW
    BMC Cancer; 2017 Jul; 17(1):506. PubMed ID: 28754109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined prognostic value of pretreatment anemia and cervical node necrosis in patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy: A large-scale retrospective study.
    Zhang LL; Zhou GQ; Li YY; Tang LL; Mao YP; Lin AH; Ma J; Qi ZY; Sun Y
    Cancer Med; 2017 Dec; 6(12):2822-2831. PubMed ID: 29034992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Tumour Response to Induction Chemotherapy has Prognostic Value for Long-Term Survival Outcomes after Intensity-Modulated Radiation Therapy in Nasopharyngeal Carcinoma.
    Peng H; Chen L; Zhang Y; Li WF; Mao YP; Liu X; Zhang F; Guo R; Liu LZ; Tian L; Lin AH; Sun Y; Ma J
    Sci Rep; 2016 Apr; 6():24835. PubMed ID: 27099096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of PD-L1 Expression of Tumor Cells with Survival Outcomes after Radical Intensity-Modulated Radiation Therapy for Non-Metastatic Nasopharyngeal Carcinoma.
    Lee VH; Lo AW; Leung CY; Shek WH; Kwong DL; Lam KO; Tong CC; Sze CK; Leung TW
    PLoS One; 2016; 11(6):e0157969. PubMed ID: 27341634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new insight into the value of total dose of cisplatin and radiation boost.
    Ou X; Zhou X; Shi Q; Xing X; Yang Y; Xu T; Shen C; Wang X; He X; Kong L; Ying H; Hu C
    Oncotarget; 2015 Nov; 6(35):38381-97. PubMed ID: 26485757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognoses and long-term outcomes of nasopharyngeal carcinoma in Han and Uyghur patients treated with intensity-modulated radiotherapy in the Xinjiang Autonomous Region of China.
    Wang R; Tan Y; Wang X; Ma L; Wang D; Hu Y; Qin Y; Liu K; Chang C; Yu J
    PLoS One; 2014; 9(11):e111145. PubMed ID: 25375129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: A 10-year experience with a large cohort and long follow-up.
    Zhang MX; Li J; Shen GP; Zou X; Xu JJ; Jiang R; You R; Hua YJ; Sun Y; Ma J; Hong MH; Chen MY
    Eur J Cancer; 2015 Nov; 51(17):2587-95. PubMed ID: 26318726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is maximum primary tumor diameter still a prognostic factor in patients with nasopharyngeal carcinoma treated using intensity-modulated radiotherapy?
    Chen Y; Hu XF; Wang Y; Chen HY; Yang L; Liu LZ; Cui CY; Liu DS; Liang SB
    BMC Cancer; 2015 Apr; 15():305. PubMed ID: 25903652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superiority of intensity-modulated radiation therapy in nasopharyngeal carcinoma with skull-base invasion.
    Liao S; Xie Y; Feng Y; Zhou Y; Pan Y; Fan J; Mi J; Qin X; Yao D; Jiang W
    J Cancer Res Clin Oncol; 2020 Feb; 146(2):429-439. PubMed ID: 31677113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment prognostic factors of survival and late toxicities for patients with nasopharyngeal carcinoma treated by simultaneous integrated boost intensity-modulated radiotherapy.
    Lin YH; Huang TL; Chien CY; Chen HC; Hsu HC; Huang EY; Wang CJ; Huang YJ; Wang YM; Huang CC; Chou SY; Liao KC; Fang FM
    Radiat Oncol; 2018 Mar; 13(1):45. PubMed ID: 29554940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the seventh and eighth editions of the UICC/AJCC staging system for nasopharyngeal carcinoma: analysis of 1317 patients treated with intensity-modulated radiotherapy at two centers.
    Yang XL; Wang Y; Liang SB; He SS; Chen DM; Chen HY; Lu LX; Chen Y
    BMC Cancer; 2018 May; 18(1):606. PubMed ID: 29843648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Outcome and Prognostic Factors of Intensity-Modulated Radiotherapy for T4 Stage Nasopharyngeal Carcinoma.
    Luo Y; Gao Y; Yang G; Lang J
    Biomed Res Int; 2016; 2016():4398498. PubMed ID: 27195286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is primary tumor volume still a prognostic factor in intensity modulated radiation therapy for nasopharyngeal carcinoma?
    Guo R; Sun Y; Yu XL; Yin WJ; Li WF; Chen YY; Mao YP; Liu LZ; Li L; Lin AH; Ma J
    Radiother Oncol; 2012 Sep; 104(3):294-9. PubMed ID: 22998947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of parapharyngeal extension in nasopharyngeal carcinoma treated with intensity modulated radiotherapy.
    Tang LL; Sun Y; Mao YP; Chen Y; Li WF; Chen L; Liu LZ; Lin AH; Li L; Ma J
    Radiother Oncol; 2014 Mar; 110(3):404-8. PubMed ID: 24183063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival analysis of patients with advanced-stage nasopharyngeal carcinoma according to the Epstein-Barr virus status.
    Peng H; Chen L; Zhang Y; Guo R; Li WF; Mao YP; Tan LL; Sun Y; Zhang F; Liu LZ; Tian L; Lin AH; Ma J
    Oncotarget; 2016 Apr; 7(17):24208-16. PubMed ID: 27008701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensity-modulated radiation therapy achieves better local control compared to three-dimensional conformal radiation therapy for T4-stage nasopharyngeal carcinoma.
    Chen JL; Huang YS; Kuo SH; Hong RL; Ko JY; Lou PJ; Wang CW
    Oncotarget; 2017 Feb; 8(8):14068-14077. PubMed ID: 27764778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of the Prognostic Nutritional Index (PNI) in predicting outcomes and guiding the treatment strategy of nasopharyngeal carcinoma (NPC) patients receiving intensity-modulated radiotherapy (IMRT) with or without chemotherapy.
    Miao J; Xiao W; Wang L; Han F; Wu H; Deng X; Guo X; Zhao C
    J Cancer Res Clin Oncol; 2017 Jul; 143(7):1263-1273. PubMed ID: 28247035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective study comparing the outcomes and toxicities of intensity-modulated radiotherapy versus two-dimensional conventional radiotherapy for the treatment of children and adolescent nasopharyngeal carcinoma.
    Qiu WZ; Peng XS; Xia HQ; Huang PY; Guo X; Cao KJ
    J Cancer Res Clin Oncol; 2017 Aug; 143(8):1563-1572. PubMed ID: 28342002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.